Tubulysins and Protein-Tubulysin Conjugates
Copyright © Targeted News Service 2024
2024-11-19
ALEXANDRIA, Virginia, Nov. 19 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12144864 B2, initially filed Dec. 20, 2019) developed by three inventors Amy Han, Hockessin, Delaware; Marcus Kelly, New York, New York; and William Olson, Yorktown Heights, New York, for "Tubulysins and protein-tubulysin conjugates." . . .